🇺🇸 kava (Piper methysticum) in United States

19 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Abdominal Discomfort — 2 reports (10.53%)
  2. Abdominal Pain — 2 reports (10.53%)
  3. Decreased Appetite — 2 reports (10.53%)
  4. Diarrhoea — 2 reports (10.53%)
  5. Fatigue — 2 reports (10.53%)
  6. Intentional Dose Omission — 2 reports (10.53%)
  7. Nausea — 2 reports (10.53%)
  8. Product Dose Omission Issue — 2 reports (10.53%)
  9. Somnolence — 2 reports (10.53%)
  10. Abdominal Distension — 1 report (5.26%)

Source database →

Other Psychiatry/Neurology approved in United States

Frequently asked questions

Is kava (Piper methysticum) approved in United States?

kava (Piper methysticum) does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for kava (Piper methysticum) in United States?

National Institutes of Health Clinical Center (CC) is the originator. The local marketing authorisation holder may differ — check the official source linked above.